“Different every step of the way” – A Dexcom G7 Update (and more) with CEO Kevin Sayer

This week, Dexcom CEO Kevin Sayer spoke to the JP Morgan Healthcare Conference about the G7 and beyond. We talk about information from that presentation and get to as many of your questions as time allows. This interview took place on Tuesday Jan 11 and much of what we discussed isn’t FDA approved. Dexcom presentation…